REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. Our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. We pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
Location: United States, California, Redwood City
Employees: 51-200
Total raised: $100M
Founded date: 2014
Investors 5
| Date | Name | Website |
| - | Spur Capit... | spurcapita... |
| 26.11.2025 | Foresite C... | foresiteca... |
| - | The Column... | thecolumng... |
| - | Illinois V... | illinoisve... |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.07.2019 | - | $100M | - |
Mentions in press and media 22
| Date | Title | Description |
| 01.09.2026 | ‘I’m still here’: Patients see early promising results from new pancreatic cancer pill | Getting your Trinity Audio player ready... When Russ Reed rang the bell marking the end of his cancer treatment in February 2025, he was declared free of disease after radiation, chemotherapy and surgery. Months later, the cancer returned. ... |
| 28.08.2026 | Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's | HONG KONG, Aug. 28, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2026 interim results. During the reporting period, the Company achieved record-high drug sales revenue, further adva... |
| 27.08.2026 | Before It Was a Cure, It Was a Waste of Money: 'Traces Thursday' Series Presents Case Studies in Scientific Patience | Stand Up for Science logo is a trademark of Stand Up for Science, and it may only be used with prior written permission. Copyright © 2026 Stand Up for Science, a 501(c)(4) non-profit organization. New weekly Substack series explores the lon... |
| 26.08.2026 | FDA approves landmark pancreatic cancer drug that’s shown to improve survival | Getting your Trinity Audio player ready... By MATTHEW PERRONE and LAURAN NEERGAARD WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a m... |
| 12.08.2026 | Silent Cancer Therapeutics Market Size to Reach USD 36.52 Billion by 2035, Driven by Precision Oncology and Advanced Cancer Therapies | Overview According to DataM Intelligence, the global silent cancer therapeutics market size was valued at USD 15.86 billion in 2025 and is forecast to reach USD 36.52 billion by 2035, expanding at a CAGR of 8.7% during 2026 to 2035. The mar... |
| 08.07.2026 | Pancreatic cancer breakthrough has big implications for early detection effort | Getting your Trinity Audio player ready... Raj Aji has been visiting San Diego regularly since last summer, and not for the weather. The retired Bay Area attorney flies south to keep appointments at Moores Cancer Center in La Jolla, getting... |
| 16.06.2026 | Johnson Johnson Myeloma Data Cuts Death Risk 53%: Cure Within Decade Gains Ground | By Richard L. Wells Published: Jun 16 2026, 22:40 PM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 01.06.2026 | ASCO 2026 Cancer Breakthroughs: Pancreatic Survival Doubles, Chemo Spared in Breast | By Adrian Parham Published: Jun 01 2026, 11:52 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 01.06.2026 | Experimental pill promises new hope for deadly pancreatic cancer | Getting your Trinity Audio player ready... By LAURAN NEERGAARD WASHINGTON (AP) — A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of ... |
| 28.05.2026 | Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors | Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, today announced the appointments of two non-executive board members, Frank Clyburn and Christopher (Ch... |
Show more